Indoleamine 2,3-dioxygenase enzyme activity correlates with risk factors for atherosclerosis: the Cardiovascular Risk in Young Finns Study.
about
Targeting the indoleamine 2,3-dioxygenase pathway in cancerAntioxidants, inflammation and cardiovascular diseaseDisturbed tryptophan metabolism in cardiovascular diseaseNeuroinflammation at the interface of depression and cardiovascular disease: Evidence from rodent models of social stressThe aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney diseaseInterferon (IFN)-γ-mediated inflammation and the kynurenine pathway in relation to bone mineral density: the Hordaland Health Study.Effect of dipterinyl calcium pentahydrate on hepatitis B virus replication in transgenic mice.Activation of NAD(P)H oxidase by tryptophan-derived 3-hydroxykynurenine accelerates endothelial apoptosis and dysfunction in vivo.Identification of a variable number of tandem repeats polymorphism and characterization of LEF-1 response elements in the promoter of the IDO1 geneInterferon-gamma-inducible kynurenines/pteridines inflammation cascade: implications for aging and aging-associated psychiatric and medical disorders.Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds.Accelerated tryptophan degradation predicts poor survival in trauma and sepsis patientsIndoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug developmentRegular consumption of black tea increases circulating kynurenine concentrations: A randomized controlled trial.Branched-chain and aromatic amino acids are predictors of insulin resistance in young adultsTryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation.Crosstalk between Tryptophan Metabolism and Cardiovascular Disease, Mechanisms, and Therapeutic ImplicationsInflammation-induced activation of the indoleamine 2,3-dioxygenase pathway: Relevance to cancer-related fatigue.The tryptophan/kynurenine pathway, systemic inflammation, and long-term outcome after kidney transplantation.Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases.Serum amine-based metabolites and their association with outcomes in primary prevention implantable cardioverter-defibrillator patients.The Relationships among Tryptophan, Kynurenine, Indoleamine 2,3-Dioxygenase, Depression, and Neuropsychological Performance.Activation of indoleamine 2,3-dioxygenase-induced tryptophan degradation in advanced atherosclerotic plaques: Tampere vascular study.A community-based study on determinants of circulating markers of cellular immune activation and kynurenines: the Hordaland Health Study.Tryptophan depletion under conditions that imitate insulin resistance enhances fatty acid oxidation and induces endothelial dysfunction through reactive oxygen species-dependent and independent pathways.Indoleamine 2,3-dioxygenase activity associates with cardiovascular risk factors: the Health 2000 study.Tryptophan-Derived 3-Hydroxyanthranilic Acid Contributes to Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Mice In Vivo.Urinary profiling of tryptophan and its related metabolites in patients with metabolic syndrome by liquid chromatography-electrospray ionization/mass spectrometry.Plasma tryptophan-kynurenine metabolites are altered in HIV infection and associated with progression of carotid artery atherosclerosis.Association of increased indoleamine 2, 3-dioxygenase with impaired natural killer cell activity in hemodialysis patients.Tryptophan metabolism activation by indoleamine 2,3-dioxygenase in adipose tissue of obese women: an attempt to maintain immune homeostasis and vascular tone
P2860
Q26775471-0A8BF152-17AA-4ACE-A3DB-AA61DEF6C434Q26823009-6F9763CC-BDC0-4492-8203-A4D25495B260Q27010486-F4EC6E79-CF5B-4946-B986-5FB8CF1EAEADQ28069771-670AFD34-9090-4D84-9E70-BBEEBB16D540Q28382992-490A08D2-A8A6-4B17-9B49-D5CEEF65FD1DQ33562127-A54C3B6C-E630-45D4-8382-CB5C39A8D324Q33784869-8089B07D-BEBB-46FB-8E00-42966FBA2C8AQ33922718-FC876F0E-52F9-47CE-9E19-D0E2936F1BB9Q34043256-0415AACB-C0DD-40C4-B712-D7958DF5FA01Q34520722-17BA4D48-8F6A-4C52-912B-B0B1ACD770F5Q34616168-6694D8EE-EEA0-42F6-A17F-7F73F5B14EF8Q35366883-B0832C11-2B6E-4F00-B212-2CF8A80AB572Q36207412-75F9BA28-E59F-4163-9938-18FBB09BC92EQ36323806-8C3AA7BD-567A-4934-BFBF-F7A580163020Q36629460-3FAF5008-4BB6-4DE0-BA76-9599CDECF58BQ37013795-CB03BB38-6562-4E2C-AE40-0916447DE2FAQ37717023-73030C7E-B055-478B-BA94-5EB4F6725B76Q38366476-87DEBE3E-5C84-488A-88BF-83D1F98E9EC5Q38793765-EEE950BF-753E-4EFC-A46D-3736BDE238F2Q39185463-F655D5A0-3F1D-493D-B5A9-D8AC6A6E4116Q40987950-02EAED58-FD12-48B2-9DD1-E3B6B38BC0B9Q42372736-95CA64EB-B67D-49BB-BA1B-D33E22931475Q43235071-741C937F-1649-4031-9867-99D7FEB050B2Q45387891-E101CB79-9B46-45B7-957E-EE6D1FD1D456Q46423068-C6BEA092-7B18-4422-A0E5-BF447CD1370BQ46486477-0FED8731-0AA4-435A-BB93-6866AB35A14EQ47697091-F6E28F59-E1A4-47FA-B2E5-66964AAECE64Q48121823-4263CAD6-780C-4900-AEFA-ED79A634AF8CQ50132706-89D9D560-CBF3-4432-BC79-3E7DB94B9C94Q54314433-0CAE3372-9507-4D75-8FB1-B62CEA1055ECQ57244071-44037351-CF22-4E57-95A0-9C2893F5517D
P2860
Indoleamine 2,3-dioxygenase enzyme activity correlates with risk factors for atherosclerosis: the Cardiovascular Risk in Young Finns Study.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Indoleamine 2,3-dioxygenase en ...... lar Risk in Young Finns Study.
@en
Indoleamine 2,3-dioxygenase en ...... lar Risk in Young Finns Study.
@nl
type
label
Indoleamine 2,3-dioxygenase en ...... lar Risk in Young Finns Study.
@en
Indoleamine 2,3-dioxygenase en ...... lar Risk in Young Finns Study.
@nl
prefLabel
Indoleamine 2,3-dioxygenase en ...... lar Risk in Young Finns Study.
@en
Indoleamine 2,3-dioxygenase en ...... lar Risk in Young Finns Study.
@nl
P2093
P2860
P1476
Indoleamine 2,3-dioxygenase en ...... ular Risk in Young Finns Study
@en
P2093
J S A Viikari
M Pertovaara
O T Raitakari
T Lehtimäki
P2860
P304
P356
10.1111/J.1365-2249.2007.03325.X
P577
2007-04-01T00:00:00Z